Inverse association between cancer and Alzheimer's disease: Results from the Framingham Heart Study

BMJ (Online)

Volumn 344, Issue 7850, 2012, Pages 19-

  Driver, Jane A ^a,b   Beiser, Alexa ^c,d,e   Au, Rhoda ^c   Kreger, Bernard E ^c,e   Splansky, Greta Lee ^e   Kurth, Tobias ^b,f,g   Kiel, Douglas P ^h   Lu, Kun Ping ^h   Seshadri, Sudha ^c   Wolf, Phillip A ^c,e  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BOSTON UNIVERSITY   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^f INSERM   (France)

^g UNIVERSITÉ DE BORDEAUX   (France)

^h HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ALZHEIMER DISEASE; ARTICLE; CANCER SURVIVOR; CASE CONTROL STUDY; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FRAMINGHAM HEART STUDY; HAZARD RATIO; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; NERVE DEGENERATION; OUTCOME ASSESSMENT; PARKINSON DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SEX; SMOKING; STROKE; TYPES OF STUDY; UNITED STATES;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; HUMANS; INCIDENCE; MALE; NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEX FACTORS; SMOKING; SURVIVAL RATE;

EID: 84859192682     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.e1442     Document Type: Article

References (52)

1. Corsellis J. Mental illness and the ageing brain. Oxford University Press, 1962.
2. DeSouky AL. The relationship between cancer and Alzheimer's disease. J Am Geriatr Soc 1992;40:1075.
3. Roe CM, Behrens MI, Xiong C, Miller JP, Morris JC. Alzheimer disease and cancer. Neurology 2005;64:895-8. (Pubitemid 40316334)
4. Roe CM, Fitzpatrick AL, Xiong C, Sieh W, Kuller L, Miller JP, et al. Cancer linked to Alzheimer disease but not vascular dementia. Neurology 2010;74:106-12.
5. Tirumalasetti F, Han L, Birkett DP. The relationship between cancer and Alzheimer's disease. J Am Geriatr Soc 1991;39:840.
6. Yamada M, Sasaki H, Mimori Y, Kasagi F, Sudoh S, Ikeda J, et al. Prevalence and risks of dementia in the Japanese population: RERF's adult health study of Hiroshima subjects. Radiation Effects Research Foundation. J Am Geriatr Soc 1999;47:189-95. (Pubitemid 29082719)
7. Bajaj A, Driver JA, Schernhammer ES. Parkinson's disease and cancer risk: a systematic review and meta-analysis. Cancer Causes Control 2010;21:697-707.
8. Driver JA, Kurth T, Buring JE, Gaziano JM, Logroscino G. Prospective case-control study of nonfatal cancer preceding the diagnosis of Parkinson's disease. Cancer Causes Control 2007;18:705-11. (Pubitemid 46988238)
9. Driver JA, Logroscino G, Buring JE, Gaziano JM, Kurth T. A prospective cohort study of cancer incidence following the diagnosis of Parkinson's disease. Cancer Epidemiol Biomarkers Prev 2007;16:1260-5. (Pubitemid 46984968)
10. Elbaz A, Peterson BJ, Bower JH, Yang P, Maraganore DM, McDonnell SK, et al. Risk of cancer after the diagnosis of Parkinson's disease: a historical cohort study. Mov Disord 2005;20:719-25. (Pubitemid 41051783)
11. Elbaz A, Peterson BJ, Yang P, Van Gerpen JA, Bower JH, Maraganore DM, et al. Nonfatal cancer preceding Parkinson's disease: a case-control study. Epidemiology 2002;13:157-64. (Pubitemid 34160490)
12. Olsen JH, Friis S, Frederiksen K, McLaughlin JK, Mellemkjaer L, Moller H. Atypical cancer pattern in patients with Parkinson's disease. Br J Cancer 2005;92:201-5. (Pubitemid 40188456)
13. Olsen JH, Tangerud K, Wermuth L, Frederiksen K, Friis S. Treatment with levodopa and risk for malignant melanoma. Mov Disord 2007;22:1252-7. (Pubitemid 47325031)
14. Behrens MI, Lendon C, Roe CM. A common biological mechanism in cancer and Alzheimer's disease? Curr Alzheimer Res 2009;6:196-204.
15. Driver JA, Lu KP. Pin1: a new genetic link between Alzheimer's disease, cancer and aging. Curr Aging Sci 2010;3:158-65.
16. Husseman JW, Nochlin D, Vincent I. Mitotic activation: a convergent mechanism for a cohort of neurodegenerative diseases. Neurobiol Aging 2000;21:815-28.
17. Lu KP. Pinning down cell signaling, cancer and Alzheimer's disease. Trends Biochem Sci 2004;29:200-9. (Pubitemid 38472025)
18. Lu KP, Liou YC, Vincent I. Proline-directed phosphorylation and isomerization in mitotic regulation and in Alzheimer's disease. Bioessays 2003;25:174-81. (Pubitemid 36222389)
19. Raina AK, Zhu X, Rottkamp CA, Monteiro M, Takeda A, Smith MA. Cyclin' toward dementia: cell cycle abnormalities and abortive oncogenesis in Alzheimer disease. J Neurosci Res 2000;61:128-33. (Pubitemid 30451799)
20. Staropoli JF. Tumorigenesis and neurodegeneration: two sides of the same coin? Bioessays 2008;30:719-27.
21. Wang W, Bu B, Xie M, Zhang M, Yu Z, Tao D. Neural cell cycle dysregulation and central nervous system diseases. Prog Neurobiol 2009;89:1-17.
22. West AB, Dawson VL, Dawson TM. To die or grow: Parkinson's disease and cancer. Trends Neurosci 2005;28:348-52. (Pubitemid 40853857)
23. Bennett DA. Is there a link between cancer and Alzheimer disease? Neurology 2010;75:1216-7.
24. Marwill SL, Freund KM, Barry PP. Patient factors associated with breast cancer screening among older women. J Am Geriatr Soc 1996;44:1210-4. (Pubitemid 26338835)
25. Scherder E, Bouma A, Borkent M, Rahman O. Alzheimer patients report less pain intensity and pain affect than non-demented elderly. Psychiatry 1999;62:265-72.
26. Dawber TR, Meadors GF, Moore FE Jr. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health Nations Health 1951;41:279-81.
27. Kreger BE, Splansky GL, Schatzkin A. The cancer experience in the Framingham Heart Study cohort. Cancer 1991;67:1-6.
28. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
29. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-44.
30. Centers for Disease Control and Prevention, Office on Smoking and Health. The health consequences of smoking: a report of the surgeon general. Centers for Disease Control and Prevention, 2004.
31. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002;346:476-83. (Pubitemid 34441738)
32. Seshadri S, Drachman DA, Lippa CF. Apolipoprotein E epsilon 4 allele and the lifetime risk of Alzheimer's disease. What physicians know, and what they should know. Arch Neurol 1995;52:1074-9.
33. Euser SM, Schram MT, Hofman A, Westendorp RG, Breteler MM. Measuring cognitive function with age: the influence of selection by health and survival. Epidemiology 2008;19:440-7. (Pubitemid 351543522)
34. Hernan MA, Takkouche B, Caamano-Isorna F, Gestal-Otero JJ. A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann Neurol 2002;52:276-84. (Pubitemid 35001493)
35. Rusanen M, Kivipelto M, Quesenberry CP Jr, Zhou J, Whitmer RA. Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia. Arch Intern Med 2011;171:333-9.
36. Van Heemst D, Mooijaart SP, Beekman M, Schreuder J, de Craen AJ, Brandt BW, et al. Variation in the human TP53 gene affects old age survival and cancer mortality. Exp Gerontol 2005;40:11-5. (Pubitemid 40138741)
37. Lu KP, Hanes SD, Hunter T. A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 1996;380:544-7. (Pubitemid 26111332)
38. Lu KP, Zhou XZ. The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease. Nat Rev Mol Cell Biol 2007;8:904-16. (Pubitemid 47622559)
39. Bao L, Sauter G, Sowadski J, Lu KP, Wang D. Prevalent overexpression of prolyl isomerase Pin1 in human cancers. Am J Pathol 2004;164:1727-37. (Pubitemid 38529775)
40. Liou Y-C, Sun A, Ryo A, Zhou XZ, Yu Z-X, Huang H-K, et al. Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration. Nature 2003;424:556-61. (Pubitemid 36975777)
41. Lu PJ, Wulf G, Zhou XZ, Davies P, Lu KP. The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature 1999;399:784-8. (Pubitemid 29293174)
42. Sultana R, Boyd-Kimball D, Poon HF, Cai J, Pierce WM, Klein JB, et al. Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: a redox proteomics analysis. Neurobiol Aging 2006;27:918-25.
43. Wulf G, Garg P, Liou YC, Iglehart D, Lu KP. Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis. EMBO J 2004;23:3397-407. (Pubitemid 39209163)
44. Lim J, Balastik M, Lee TH, Nakamura K, Liou YC, Sun A, et al. Pin1 has opposite effects on wild-type and P301L tau stability and tauopathy. J Clin Invest 2008;118:1877-89. (Pubitemid 351632390)
45. Segat L, Pontillo A, Annoni G, Trabattoni D, Vergani C, Clerici M, et al. PIN1 promoter polymorphisms are associated with Alzheimer's disease. Neurobiol Aging 2007;28:69-74. (Pubitemid 44802916)
46. Lu J, Hu Z, Wei S, Wang LE, Liu Z, El-Naggar AK, et al. A novel functional variant (-842G>C) in the PIN1 promoter contributes to decreased risk of squamous cell carcinoma of the head and neck by diminishing the promoter activity. Carcinogenesis 2009;30:1717-21.
47. Zotova E, Nicoll JA, Kalaria R, Holmes C, Boche D. Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy. Alzheimers Res Ther 2010;2:1.
48. Webber KM, Raina AK, Marlatt MW, Zhu X, Prat MI, Morelli L, et al. The cell cycle in Alzheimer disease: a unique target for neuropharmacology. Mech Ageing Dev 2005;126:1019-25. (Pubitemid 41253852)
49. Seigers R, Fardell JE. Neurobiological basis of chemotherapy-induced cognitive impairment: a review of rodent research. Neurosci Biobehav Rev 2011;35:729-41.
50. Heck JE, Albert SM, Franco R, Gorin SS. Patterns of dementia diagnosis in surveillance, epidemiology, and end results breast cancer survivors who use chemotherapy. J Am Geriatr Soc 2008;56:1687-92.
51. Baxter NN, Durham SB, Phillips KA, Habermann EB, Virning BA. Risk of dementia in older breast cancer survivors: a population-based cohort study of the association with adjuvant chemotherapy. J Am Geriatr Soc 2009;57:403-11.
52. Surma-aho O, Niemela M, Vilkki J, Kouri M, Brander A, Salonen O, et al. Adverse long-term effects of brain radiotherapy in adult low-grade glioma patients. Neurology 2001;56:1285-90. (Pubitemid 32455284)